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Abstract
We report an unusual case of HIV-related immune reconstitution inflammatory syndrome, presenting as suspected
AIDS-related lymphoma. Symptoms, initial investigations including fine-needle biopsy and 18F-FDG PET/CT scan
were highly compatible with high grade AIDS-related lymphoma, however subsequently IRIS was diagnosed. We
discuss pitfalls in the interpretation of diagnostic results in ARL versus IRIS.
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Background
Immune inflammatory reconstitution syndrome (IRIS) in
HIV patients after initiation of combination antiretroviral
therapy (cART) has been increasingly recognized. IRIS is
defined as a paradoxical worsening or unmasking of infec-
tions, autoimmune diseases or tumours after initiating of
cART, and is usually seen when the initial CD4 count is
low. The pathological basis is thought to be recovery of
the immune system, and IRIS is often described to occur
in patients infected with mycobacteria. The diagnosis of
IRIS is often challenging as differential diagnosis is com-
plex, including opportunistic infection, drug failure/toxi-
city or malignancy. The most common symptoms seen in
IRIS are fever, lymphadenopathy and pulmonary symp-
toms [1] which resemble symptoms seen in patients with
AIDS related lymphoma (ARL). In the literature, cases of
IRIS, mimicking relapse of ARL have been described [2].
In addition, high rate of ARL has recently been reported
shortly after initiation of newer-class antiretrovirals [3]
which makes the distinction between ARL and IRIS
important. As seen in the present case report, the distinc-
tion between ARL and IRIS may cause major difficulties.
Case report
A 37-year homosexual male was admitted to a Gastroen-
terology Clinic because of six weeks of non-bloody diar-
rhea, abdominal pain and marked weight loss. Findings at
sigmoideoscopy suggested Crohns Disease. After one
month of steroid treatment most symptoms had subsided
with colonoscopy and x-ray of the small intestine then
demonstrating only mild colitis without involvement of
the terminal ileum. In the following weeks, steroids were
completely tapered; however HIV-testing was not
performed.
Four month after the first admission, diarrhea and
weightloss recurred. At readmission to hospital, moder-
ate anemia and thrombocytopenia were found. An
abdominal ultrasound demonstrated splenomegaly. Test-
ing for HIV was positive with signs of severe immunode-
fiency with a CD4 count of 32 cells/microliter.
Combination antiretroviral treatment (cART) treatment
was initiated. However, during the next five weeks the
patients overall condition slowly deteriorated with severe
weight loss, fever and night sweats. At hospital admission
at five weeks of cART, the patient was now severely pro-
strated with anemia and high LDH. CT scan revealed
bulky mediastinal and retroperitoneal glands, the largest
measuring 4.5 × 6 × 9 cm. ARL was suspected.
An ultrasound-guided transesophagal needle aspiration
cytology and biopsy of a mediastinal lymph node was per-
formed. The cytology was suggestive of widespread tumor
cell infiltration, Figure 1. In this biopsy, the supposed
malignant cells contained multiple mitotic figures, with a
rich amount of cytoplasma, large dark nuclei together with
several apoptotic cells. Malignant cells were positive for
CD30, EMA, Ki-67 and vimentin, and some were positive
for MelanA and CD45. All tumor cells were negative for
KL1, TTF-1, chromogranine, alfa feto protein and CD15.
No acid-fast bacilli and no granulomas were seen. On the
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anaplastic large cell lymphoma, was strongly suspected.
However a rebiopsy was recommended for definitive clas-
sification. One week after the first biopsy, and seven weeks
after initation of cART, ultrasonic guided biopsy from the
previously observed abdominal lymph nodes was
attempted, but surprisingly enlarged lymph nods could
not be demonstrated by ultrasound. Instead a lymph node
was removed by mediastinoscopy.
Immediately after this biopsy, pre-treatment with a sin-
gle dose of vincristine (1 mg) and 100 mg of prednisolone
daily for one week was started according to the R-CHOP-
14 protocol [2] due to the persistent severe B-symptoms
and the high suspicion of lymphoma. However, no malig-
nant cells were detected in the mediastinal lymph node
removed. Instead granulomas with epitheloid cells and
necrosis were observed, Figure 2. Intensive workup for
mycobacterial disease was, however, negative. The biopsy
was PCR negative for mycobacteria. Sputum, gastric
lavage and peripheral blood were all culture and PCR
negative for tuberculous and non-tuberculous mycobac-
teriae. In addition, interferon-gamma release assay testing
for latent TB (Quantiferon Gold-TB test) was negative as
well. An 18F-FDG PET/CT scan two weeks after the first
CT-scan and eight weeks after initiation of cART now
revealed metabolic active but significantly regressed
lymph nodes in mediastinum and retroperitoneum.
Because of these findings, the diagnosis of suspected ARL
was reconsidered, and IRIS was suspected. Steroid treat-
ment was slowly tapered.
Repeated 18F-FDG PET/CT scan 11 weeks after initia-
tion of cART showed both further structural and meta-
bolic regression, Figure 3. At this time point, serum LDH
had decreased, and the hemoglobin and platelet counts
were almost normalized.
A final 18F-FDG PET/CT scan 18 weeks after initiation
of cART revealed complete regression of all previous
pathologic findings, at which point steroid treatment was
discontinued. During continued antiretroviral therapy and
two years of follow-up the patient has had a good immu-
nologic recovery without signs of relapse.
Discussion
The present case demonstrates pitfalls in interpretation
of the standard techniques when diagnosing a patient
with ARL versus IRIS.
At presentation, ARL was strongly suspected on the
basis of initial biopsy findings compatible with high-
grade lymphoma and PET/CT findings suggesting bulky,
PET-positive malignancy.
Due to the high suspicion of ARL, pre-treatment with
steroids was initiated, however a second biopsy only
showed granulomas and inflammation, which were com-
patible with IRIS.
Patients with HIV and low CD4 counts presents a parti-
cular challenge in the interpretation of 18F-FDG PET/CT
s c a n sa sav a r i e t yo fi n f e c t i o n sa n dm a l i g n a n c i e sm a y
cause increased FDG uptake [4]. In the present case, the
pronounced lymph node enlargements and increased
FDG-uptake was believed to be primarily compatible with
aggressive ARL, however, as shown, the presence of HIV
should always increase the index of suspicion that pathol-
ogy other than lymphoma could be present.
The pathogenesis of IRIS remains unclear, but is
believed to be mediated by the recovery of immune
responses to pre-existing provoking antigens, usually
opportunistic pathogens. The main risk factors for IRIS
a r es e v e r eC D 4l y m p h o p e n i aa n di n f e c t i o na tc A R T
initiation, which leads to a dysregulated T-cell response
to antigen when severe immunosuppression reverses. In
tuberculosis-associated IRIS, the exacerbation reflects
Figure 1 Initial fine needle cytology from mediastinal gland
suggestive of widespread tumor cell infiltration.
Figure 2 Mediastinal gland showing granulomas with
epitheloid cells and necrosis.
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followed by a storm of pro-inflammatory Th1 cytokines
which leads to lymph node enlargement and granuloma
formation [5]. However, the finding of granulomatous
inflammation is unspecific and has also been described in
connection with IRIS caused by fungi or protozoa [6].
Noninfectious etiologies to IRIS have also been reported
[7] in association with autoimmune manifestations such
as as sarcoidosis and sarcoid-like pulmonary disorders
[8,9]. In such cases, it is presumed that an autoimmune
reaction triggered by self antigens leads to a Th1 respons
followed by a granulomatous reaction [10].
Sarcoid-like granulomas have often been described in
association with lymphomas, both in Hodgkins disease
and in Non-Hodgkin lymphomas [11]. Similar to HIV-
associated IRIS, it is believed that aberrant cytokine pro-
duction in the tumor cells or other cells composing the
tumor background may provoke a granulomatous
reaction.
T h ee x a c tc a u s eo fI R I Si nt h i sp r e s e n tc a s er e m a i n s
unknown. The most likely explanation for the observa-
tion of granulomas are infection with Mycobacteria or
fungi [12]. However we believe that the clinical course
and microbiological findings in our case were not
directly compatible with IRIS caused by opportunistic
infections since mycobacterial cultures and extensive
investigation for infections were negative and recovery
occurred in the absence of anti-infectious therapy.
Figure 3 18F-FDG- PET/CT findings. Baseline: At presentation high metabolic activity in mediastinal mass. After 3 weeks: Both structural and
metabolic regression. After 10 weeks: Complete structural and metabolic remission.
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was a needle biopsy but with limited material. Interpreta-
tion of fine needle aspiration cytology and biopsy is also
a particular challenge within HIV-patients. Lowe and
coworkers found, that a definitive diagnosis could not be
made with fine needle aspiration cytology in 31% of HIV
patients with lymphadenopathy and therefore an open
lymph node biopsy was often needed. Although fine nee-
dle aspiration cytology is often inadequate for definitive
diagnosis of lymphoma, it is unusual to misinterpret
inflammation as compatible with malignancy [13].
In conclusion this case illustrates the pitfalls of stan-
dard techniques, including 18F-FDG PET/CT scan and
microscopy of a biopsy in the setting of HIV. If an HIV
positive patient with a low CD4 count develops signs of
ARL shortly after the introduction of cART, clinicians
must be aware that IRIS could be the cause. In such
cases, definitive diagnostic lymph node excisional biopsy
is mandatory.
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